EAM
SAGE

Eagle Asset Management’s Sage Therapeutics SAGE Stock Holding History

Eagle Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-480,181
Closed -$67.4M – 656
2019
Q3 		$67.4M Sell
480,181
-57,469
-11% -$9.61M 0.35% 108
2019
Q2 		$98.4M Buy
537,650
+1,978
+0.4% +$338K 0.5% 61
2019
Q1 		$85.2M Sell
535,672
-111,670
-17% -$16.2M 0.45% 70
2018
Q4 		$62M Sell
647,342
-6,672
-1% -$764K 0.39% 90
2018
Q3 		$92.4M Buy
654,014
+71,032
+12% +$11M 0.45% 63
2018
Q2 		$91.3M Sell
582,982
-32,231
-5% -$5.06M 0.49% 55
2018
Q1 		$99.1M Sell
615,213
-3,815
-0.6% -$648K 0.54% 44
2017
Q4 		$102M Sell
619,028
-8,003
-1% -$776K 0.56% 40
2017
Q3 		$39.7M Sell
627,031
-40,165
-6% -$3.15M 0.23% 150
2017
Q2 		$53.1M Sell
667,196
-950
-0.1% -$68.7K 0.32% 105
2017
Q1 		$47.5M Sell
668,146
-3,660
-0.5% -$214K 0.3% 102
2016
Q4 		$34.3M Buy
671,806
+41,312
+7% +$1.95M 0.23% 139
2016
Q3 		$29M Sell
630,494
-243,430
-28% -$9.91M 0.2% 164
2016
Q2 		$26.3M Buy
873,924
+27,319
+3% +$911K 0.18% 166
2016
Q1 		$27.1M Sell
846,605
-17,765
-2% -$625K 0.19% 168
2015
Q4 		$50.4M Buy
864,370
+112,567
+15% +$5.58M 0.34% 99
2015
Q3 		$31.8M Sell
751,803
-6,419
-0.8% -$396K 0.22% 156
2015
Q2 		$55.4M Buy
+758,222
New +$48.7M 0.31% 117

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Eagle Asset Management's SAGE Position: Q4 2019 in Review

Eagle Asset Management sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 480,181 shares — an estimated $67.4M sold.

Eagle Asset Management first reported a position in SAGE in Q2 2015 and held it in 18 quarters. The position peaked at $102M in Q4 2017. 266 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • Eagle Asset Management reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Eagle Asset Management sold 480,181 Sage Therapeutics shares in Q4 2019, an estimated $67.4M.
  • Eagle Asset Management first reported a position in Sage Therapeutics in Q2 2015 and held it in 18 quarters.
  • Eagle Asset Management's Sage Therapeutics position peaked at $102M in Q4 2017.
  • 266 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on Eagle Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.